Simple Three-Point Score Predicts Survival in Prostate Cancer Patients Receiving Radioligand Therapy
An independent study of 243 patients confirms that the Bellmunt Risk Score, based on performance status, hemoglobin, and liver metastases, ...
An independent study of 243 patients confirms that the Bellmunt Risk Score, based on performance status, hemoglobin, and liver metastases, ...
A new dual-targeting radioligand that binds both fibroblast activation protein and integrin αvβ3 showed sixfold higher tumor uptake than a ...
A new review maps how PSMA, SSTR, CXCR4, and FAP targets are advancing radionuclide theranostics from proven prostate cancer and ...
A UCLA case report published in CA: A Cancer Journal for Clinicians follows one patient through three prostate cancer recurrences ...
A new translational study shows that adding RANKL inhibition to lutetium-177-labeled bisphosphonate radioligand therapy stabilizes the bone microenvironment and sharply ...
UCLA researchers at the ASTRO 2026 annual meeting present genetic testing, MRI-guided radiation, and radioligand therapy studies aimed at personalizing ...
A first-in-kind pilot study reports that systemic targeted alpha therapy with actinium-225 labeled PSMA was feasible, well tolerated, and showed ...
The largest dosimetry study of terbium-161 PSMA-617 radioligand therapy shows high tumor-absorbed doses with tolerable organ exposure in prostate cancer ...
A prospective study of 142 patients finds that elevated baseline CEA independently predicts shorter survival in men with metastatic castration-resistant ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine